Pulsatile High-dose Furmonertinib in EGFR-mutant NSCLC With Leptomeningeal Metastasis

Clinical trial NCT07348965 · RECRUITING

Trial details

NCT number: NCT07348965
Sponsor: Guangzhou University of Traditional Chinese Medicine
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

NSCLC (Advanced Non-small Cell Lung Cancer)Leptomeningeal Metastasis Furmonertinib EGFR Activating Mutation

Start date: 2026-03-01
Primary completion: 2028-09-30
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.